troglitazone has been researched along with Arthritis in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Arthritis: Acute or chronic inflammation of JOINTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawahito, Y | 1 |
| Kondo, M | 1 |
| Tsubouchi, Y | 1 |
| Hashiramoto, A | 1 |
| Bishop-Bailey, D | 1 |
| Inoue, K | 1 |
| Kohno, M | 1 |
| Yamada, R | 1 |
| Hla, T | 1 |
| Sano, H | 1 |
1 other study available for troglitazone and Arthritis
| Article | Year |
|---|---|
15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats.
Topics: Animals; Apoptosis; Arthritis; Arthritis, Experimental; Arthritis, Rheumatoid; Cells, Cultured; Chro | 2000 |